Author:
Li L,Wei X H,Pan Y P,Li H C,Yang H,He Q H,Pang Y,Shan Y,Xiong F X,Shao G Z,Zhou R L
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference31 articles.
1. Abdul-Ghani R, Serra V, Györffy B, Jürchott K, Solf A, Dietel M et al. (2006). The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene 25: 1743–1752.
2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM . (2003). P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468–7485.
3. Barancík M, Bohácov V, Sedlák J, Sulov Z, Breier A . (2006). LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci 29: 426–434.
4. Cabrita MA, Hobman TC, Hogue DL, King KM, Cass CE . (1999). Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. Cancer Res 59: 4890–4897.
5. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH . (2007). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFkappaB pathway. Cancer Lett 259: 111–118.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献